Press Releases
December 31, 2025
Danish Entrepreneur Shares 33-Year China Journey at Jiaxing Opening-Up Symposium
Indeterminate
GlobeNewswire, Inc.
December 31, 2025
Total number of shares and voting rights in Zealand Pharma as of December 31, 2025
Indeterminate
GlobeNewswire, Inc.
December 23, 2025
High Protein Powders Market Size to Worth USD 50.43 Billion by 2035, Driven by Clean-Label Nutrition, AI Formulation, and Plant-Based Demand
Indeterminate
GlobeNewswire, Inc.
December 22, 2025
Frozen Yogurt Market Set to Reach USD 11.53 Billion by 2035, Driven by Health Trends and Flavor Innovation
Indeterminate
GlobeNewswire, Inc.
December 18, 2025
Knight Therapeutics Announces Health Canada Approval for WYNZORA® to Treat Psoriasis Vulgaris
Indeterminate
GlobeNewswire, Inc.
December 18, 2025
Fruit Snacks Market Size to Worth 48.60 billion by 2035, Fueled by Health, Innovation, and AI-Driven Trends
Indeterminate
GlobeNewswire, Inc.
December 17, 2025
Missouri Farm Bureau partners with Rezilient Health to provide comprehensive primary care benefit to employees
Neutral
EIN Presswire
December 8, 2025
Medical Device Testing Market Expected to Surpass USD 24.32 Billion by 2034
Indeterminate
GlobeNewswire, Inc.
December 16, 2025
WakeMed becomes one of the first U.S. health systems to integrate Rezilient CloudClinics
Neutral
EIN Presswire
December 15, 2025
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
Indeterminate
GlobeNewswire, Inc.
December 15, 2025
IIP Denmark (IIP) Selects Harvest by Dasseti to Elevate ESG and Investment Data Management
Neutral
EIN Presswire
December 11, 2025
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Indeterminate
GlobeNewswire, Inc.
December 11, 2025
Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health
Indeterminate
GlobeNewswire, Inc.
December 5, 2025
Automated Pharmacy Compounding Systems Market Growing Toward USD 5.27 Billion in 2035
Indeterminate
GlobeNewswire, Inc.
December 30, 2025
Drug Trials Snapshots: LYNKUET
Gov't Institution
U.S. Food and Drug Administration
Owner: American Government
December 31, 2025
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders
Indeterminate
GlobeNewswire, Inc.